Pharmaceutical Grade Magnesium Hydroxide Market, By Purity (<=99% and >99%), By End User (Pharmaceutical Companies, Contract Research Organizations, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Description

Pharmaceutical Grade Magnesium Hydroxide Market is estimated to be valued at USD 785.3 Mn in 2026 and is expected to reach USD 1,155.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 785.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.70%	2033 Value Projection:	USD 1,155.8 Mn

Pharmaceutical grade magnesium hydroxide popularly known as milk of magnesia, is an ultra-pure inorganic compound which conform the stringent standards specified by various pharmacopoeia such as United States Pharmacopeia (USP) and European Pharmacopoeia (EP). In addition, the product finds its extensive application as active pharmaceutical ingredient (API) and an excipient in a range of applications such as antacids, laxatives, and magnesium supplements and oral formulations as an affordable and safe ingredient owing to its ultra-pure nature, effective buffering properties and benign safety profile.

The global pharmaceutical grade magnesium hydroxide market is projected to experience substantial growth owing to the surging incidences of various gastrointestinal disorders and increasing sales of pharmaceutical as well as nutraceuticals products. Growing investment in the pharmaceutical sector in various developing countries and innovation in the purification processes and development of high-quality pharmaceutical ingredients are also likely to influence the market growth over the forecasted period.

Market Dynamics

The global pharmaceutical grade magnesium hydroxide market is poised for significant growth driven by the rising prevalence of gastrointestinal disorders, coupled with the increasing demand for antacids, laxatives and magnesium supplements, and the overall growth of the pharmaceutical and nutraceutical industry. Additionally, increasing pharmaceutical manufacturing activities in developing countries and ever-increasing standards set by pharmacopeia of high purity pharmaceutical ingredients and excipients has further strengthened the demand for pharmaceutical grade magnesium hydroxide.

However, a number of constraints are present in the market, such as stringent regulatory compliance requirements, fluctuating raw material availability, and energy-intensive production processes. Nevertheless, the development of advanced pharmaceutical formulations, increasing demand for pediatric and geriatric medicines, and the growing adoption of self-medication and over-the-counter (OTC) healthcare products will offer new opportunities for growth in the pharmaceutical grade magnesium hydroxide market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical grade magnesium hydroxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Huber Engineered Materials, Kyowa Chemical Industry Co., Ltd., Nedmag B.V., Konoshima Chemical Co., Ltd., ICL Performance Products LP, Martin Marietta Magnesia Specialties, LLC, Tateho Chemical Industries Co., Ltd., ICL Group Ltd., Nabaltec AG, and UBE Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical grade magnesium hydroxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical grade magnesium hydroxide market

Market Segmentation

Purity Insights (Revenue, USD Mn, 2021 - 2033)
<=99%
>99%
End User Insights (Revenue, USD Mn, 2021 - 2033)
Pharmaceutical Companies
Contract Research Organizations
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Huber Engineered Materials
Kyowa Chemical Industry Co., Ltd.
Nedmag B.V.
Konoshima Chemical Co., Ltd.
ICL Performance Products LP
Martin Marietta Magnesia Specialties, LLC
Tateho Chemical Industries Co., Ltd.
ICL Group Ltd.
Nabaltec AG
UBE Corporation

Product Code: CMI9837

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Pharmaceutical Grade Magnesium Hydroxide Market, By Purity
- Global Pharmaceutical Grade Magnesium Hydroxide Market, By End User
- Global Pharmaceutical Grade Magnesium Hydroxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Pharmaceutical Grade Magnesium Hydroxide Market, By Purity, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
<=99%
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
>99%
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Pharmaceutical Grade Magnesium Hydroxide Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Pharmaceutical Grade Magnesium Hydroxide Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Company Profile
- Huber Engineered Materials
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kyowa Chemical Industry Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nedmag B.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Konoshima Chemical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ICL Performance Products LP
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Martin Marietta Magnesia Specialties, LLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Tateho Chemical Industries Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ICL Group Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nabaltec AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- UBE Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

8. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. References and Research Methodology

References
Research Methodology
About us